Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Geron Corp (NQ: GERN ) 3.895 -0.185 (-4.53%) Streaming Delayed Price Updated: 11:19 AM EDT, May 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4,367,105 Open 4.140 Bid (Size) 3.890 (426) Ask (Size) 3.900 (27) Prev. Close 4.080 Today's Range 3.840 - 4.200 52wk Range 1.680 - 4.300 Shares Outstanding 508,766,846 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights Today 7:00 EDT From Geron Corporation Via Business Wire The Top 3 Penny Stocks to Buy in April 2024 Today 6:46 EDT Our economy is experiencing some decline, but it will rebound, use this opportunity to invest in these penny stocks to buy. Via InvestorPlace Topics Economy Exposures Economy Performance YTD +82.01% +82.01% 1 Month +22.87% +22.87% 3 Month +111.68% +111.68% 6 Month +101.81% +101.81% 1 Year +57.06% +57.06% More News Read More Navigating 10 Analyst Ratings For Geron April 29, 2024 Via Benzinga Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday April 26, 2024 Via Benzinga The Latest Analyst Ratings For Geron April 10, 2024 Via Benzinga Geron Corp. (NASDAQ: GERN) Near Top of Volume Charts in Friday Trading March 15, 2024 Via Investor Brand Network Geron to Announce First Quarter 2024 Financial Results on May 2, 2024 April 25, 2024 From Geron Corporation Via Business Wire 3 Red-Hot Biotech Rockets Blasting Off in 2024 April 24, 2024 Via InvestorPlace Topics Economy Exposures Economy Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 18, 2024 From Geron Corporation Via Business Wire Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday April 12, 2024 Via Benzinga Topics Stocks Exposures US Equities Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me' April 11, 2024 Via Benzinga Geron to Participate at Upcoming Investor Conferences in April April 03, 2024 From Geron Corporation Via Business Wire Geron Stock Doubles After Imetelstat Receives FDA Panel Approval March 20, 2024 Via MarketBeat Exposures Product Safety Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants March 19, 2024 From Geron Corporation Via Business Wire Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket March 18, 2024 Via Benzinga Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session March 18, 2024 Via Benzinga Inflation Squeezes Stocks, Bitcoin Slips To $68,000, While Commodities On Track For Best Week In Months: What's Driving Markets Friday? March 15, 2024 Via Benzinga Topics Economy Exposures Interest Rates What's Going On With Cancer Focused-Geron Stock On Friday? March 15, 2024 Via Benzinga Exposures Product Safety Why Is Geron (GERN) Stock Up 94% Today? March 15, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session March 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 14, 2024 Via Benzinga Geron Stock Is Soaring After Hours: What's Going On? March 14, 2024 Via Benzinga Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS March 14, 2024 From Geron Corporation Via Business Wire Why Geron Stock Is Falling Today March 12, 2024 Via Benzinga Exposures Product Safety FDA Casts Doubts On Geron's Blood Cancer Drug, But Analyst Sees High Probability For Imetelstat's Potential Approval For MDS Anemia Treatment March 12, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
